Aptamer BC 007’s Affinity to Specific and Less-Specific Anti-SARS-CoV-2 Neutralizing Antibodies

Aptamer BC 007’s Affinity to Specific and Less-Specific Anti-SARS-CoV-2 Neutralizing Antibodies

COVID-19 is a pandemic respiratory disease that is caused by the highly infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Anti-SARS-CoV-2 antibodies are essential weapons that a patient with COVID-19 has to combat the disease. When now repurposing a drug, namely an aptamer tha...

Full description

Bibliographic Details
Main Authors: Annekathrin Haberland, Oxana Krylova, Heike Nikolenko, Peter Göttel, Andre Dallmann, Johannes Müller, Hardy Weisshoff
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Viruses
Subjects:
aptamer
autoantibody
BC 007
COVID-19
re-purposing
SARS-CoV-2 antibody
Online Access:https://www.mdpi.com/1999-4915/13/5/932

Internet

https://www.mdpi.com/1999-4915/13/5/932

Similar Items